TB-500 vs Thymosin Beta-4
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
A synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). NOT the same as TB-4 - TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.
Also: TB-4, Tβ4
The full 43-amino acid protein that TB-500 is derived from. Naturally occurring in most human tissues, TB-4 has a shorter half-life (~2 hours) compared to its synthetic fragment TB-500 (~2-4 days). Often mislabeled as 'TB-500' by vendors in premixed products.
Key Comparison Insights
- Both peptides belong to the Healing category, suggesting similar primary applications.
Detailed Comparison
| Attribute | TB-500 | Thymosin Beta-4 |
|---|---|---|
| Category | Healing | Healing |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | TB-500 is derived from the active region of the full Thymosin Beta-4 protein. It promotes cell migration by binding to and sequestering actin, a protein essential for cell movement. It upregulates actin expression, promotes angiogenesis, reduces inflammation, and facilitates hair follicle stem cell migration for wound healing. | Thymosin Beta-4 is the primary actin-sequestering protein in mammalian cells. It regulates actin polymerization, promotes cell migration, angiogenesis, and wound healing. TB-4 also has anti-inflammatory properties and promotes stem cell differentiation. The active healing region of TB-4 was isolated to create the synthetic fragment TB-500. |
| Common Dosing | 2-2.5 mg twice weekly (loading), then 2.5 mg once weekly (maintenance) 2x weekly for 4-6 weeks, then 1x weekly | 2.5-5 mg 2-3x weekly 2-3x weekly |
| Administration | Subcutaneous or intramuscular injection | Subcutaneous injection, topical for eye conditions |
| Typical Duration | 4-6 weeks loading, then maintenance | 4-8 weeks typical protocol |
| Best Time to Take | Morning or evening | Morning or split doses |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Research shows significant wound healing acceleration, cardiac tissue repair after heart attack in animal models, and anti-inflammatory effects. Studies demonstrate improved recovery from dermal wounds and muscle injuries. Human clinical trials ongoing for wound healing applications. | Extensive research on wound healing, cardiac repair, and tissue regeneration. Studies show TB-4 accelerates dermal wound closure and promotes corneal epithelial healing. Research in cardiac repair shows improved outcomes post-myocardial infarction in animal models. The shorter half-life means more frequent dosing compared to TB-500. |
Frequently Asked Questions: TB-500 vs Thymosin Beta-4
What is the difference between TB-500 and Thymosin Beta-4?
TB-500 is a healing peptide that a synthetic 17-amino acid fragment of thymosin beta-4 (tb-4). not the same as tb-4 - tb-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. note: many vendors mislabel tb-4 as 'tb-500' in premixed products. Thymosin Beta-4 is a healing peptide that the full 43-amino acid protein that tb-500 is derived from. naturally occurring in most human tissues, tb-4 has a shorter half-life (~2 hours) compared to its synthetic fragment tb-500 (~2-4 days). often mislabeled as 'tb-500' by vendors in premixed products. The main differences lie in their mechanisms of action and clinical applications.
Which is better, TB-500 or Thymosin Beta-4?
Neither is universally "better" - the choice depends on your specific goals. TB-500 is typically used for healing purposes, while Thymosin Beta-4 is used for healing. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can TB-500 and Thymosin Beta-4 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using TB-500 and Thymosin Beta-4 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.
Related Comparisons
View Full Peptide Profiles
Educational Information Only
This comparison of TB-500 and Thymosin Beta-4 is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.